NorthWest Biotherapeutics Inc (NWBO)

[brooktrail1933]

Could I add that the 5 year survival rate of 6.8% is likely inflated by the inclusion of IDH-mutant patients, which were included in the definition of GBM for most of the trials included in that figure. And we know IDH-mutant patients were few and far between in the DCVax-L trial. Actual 5 year survival for true GBM is much less than 5%.